Afuco™ Anti-NGF ADCC Therapeutic Antibody (Ranevetmab), ADCC Enhanced
This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant monoclonal antibody to NGF. Ranevetmab is a caninized monoclonal antibody that can be potentially used in the treatment of Osteoarthritis (OA).
Supplier | Creative Biolabs |
---|---|
Product # | AFC-TAB-031ML |
Pricing | Inquiry |
Host | Canine |
Target | NGF |
Species Reactivity | Canine |
Type | ADCC enhanced antibody |
Applications | ELISA, IHC, FC, IP, IF, Inhib |
Storage | Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles. |